SCHEMBL29516391

SCHEMBL29516391

Cc1ccccc1Oc1nc(NS(=O)(=O)c2cnn(C)c2)nc2c1CCC(C)(C)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.36
▸ HTR7 P34969 5/20 0.36
▸ DRD2 P14416 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ SLC22A12 Q96S37 1/20 0.34
▸ THRB P10828 1/20 0.33
▸ NLRP3 Q96P20 1/20 0.32
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ KMT2A Q03164 2/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ EGFR P00533 1/20 0.30
▸ FGFR1 P11362 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287273 1.00 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL26813338 0.95 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL29516324 0.95 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL26813358 0.83 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL29516117 0.83 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL24287494 0.82 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL29516148 0.82 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL26813383 0.78 HTR1A (0.40) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL29566900 0.76 HTR1A (0.43) HTR1AHTR7DRD2HTR6SLC22A12
SCHEMBL24309827 0.76 HTR1A (0.43) HTR1AHTR7DRD2HTR6SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225750-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback